INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,266,522 | -35.9% | 71,680 | -17.3% | 0.02% | -32.1% |
| Q2 2023 | $3,533,261 | +14.5% | 86,642 | +4.7% | 0.03% | +7.7% |
| Q1 2023 | $3,084,763 | +2.1% | 82,768 | -4.5% | 0.03% | -3.7% |
| Q4 2022 | $3,022,695 | -24.6% | 86,635 | +20.9% | 0.03% | -27.0% |
| Q3 2022 | $4,010,000 | -2.7% | 71,658 | -10.0% | 0.04% | +12.1% |
| Q2 2022 | $4,122,000 | -25.7% | 79,639 | +4.4% | 0.03% | 0.0% |
| Q1 2022 | $5,546,000 | -34.3% | 76,319 | +6.8% | 0.03% | -25.0% |
| Q4 2021 | $8,447,000 | +10.7% | 71,442 | +25.6% | 0.04% | -4.3% |
| Q3 2021 | $7,630,000 | +54.5% | 56,879 | +86.5% | 0.05% | +58.6% |
| Q2 2021 | $4,937,000 | +97.7% | 30,491 | -2.0% | 0.03% | +81.2% |
| Q1 2021 | $2,497,000 | – | 31,108 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |